Arroyo Hugo A
Hospital de Pediatría Prof. Dr. Juan P Garrahan, Buenos Aires, Argentina. E-mail:
Medicina (B Aires). 2019;79 Suppl 3:71-76.
Juvenile myasthenia gravis is a rare autoimmune disease, which has made it difficult to collect data from prospective randomized controlled trials to evaluate the efficacy and results of different treatments. Although there are differences between the juvenile myasthenia gravis and that of the adult, the data provided by some researches in adults in the treatment of juvenile myasthenia gravis have been used. The different therapeutic options will be evaluated, with the different evidences that sustain it and a treatment algorithm will be elaborated keeping always in mind that each patient offers us different challenges.
青少年重症肌无力是一种罕见的自身免疫性疾病，这使得从前瞻性随机对照试验中收集数据以评估不同治疗方法的疗效和结果变得困难。尽管青少年重症肌无力与成人重症肌无力存在差异，但成人中一些关于青少年重症肌无力治疗的研究提供的数据仍被采用。将评估不同的治疗选择及其相应证据，并制定一种治疗算法，同时始终牢记每个患者都会带来不同的挑战。
